MedPath

SUPRAFLEX CRUZ PMCF Study ( rEpic05 )

Recruiting
Conditions
Coronary Artery Disease (CAD)
Ischemic Heart Disease
Interventions
Device: SUPRAFLEX CRUZ
Registration Number
NCT05617599
Lead Sponsor
Fundación EPIC
Brief Summary

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Medical Device Regulations (MDR) with multivessel coronary disease requirements in all the CONSECUTIVE patients treated with (SUPRAFLEX CRUZ).

Detailed Description

The objective of this multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study is to confirm and support the clinical safety and performance of the SUPRAFLEX CRUZ in a NON-SELECTED, Real World population under daily clinical practice when used as intended by the manufacturer to meet EU Medical Device regulation requirements for post-market clinical follow-up.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
508
Inclusion Criteria
  • ≥ 18 years old and;
  • Patients treated with SUPRAFLEX CRUZ according to routine hospital practice and following instructions for use
  • Patients with multivessel coronary artery disease (understood as that which affects more than one territory of the major epicardial coronary arteries - anterior descending, circumflex, right coronary artery) who is treated with more than 1 stent under study in lesions located in more than 1 of the aforementioned arteries.
  • Substudy: Patients with Ejection Fraction <45% by Echocardiography
  • Informed consent signed
Exclusion Criteria
  • Not meet inclusion criteria
  • Contraindication for antiplatelet treatment
  • Patient life expectancy less than 12 months

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Coronary Artery Disease (CAD)SUPRAFLEX CRUZ-
Primary Outcome Measures
NameTimeMethod
Target Lesion Failure (TLF)12 months

Rate of target lesion failure

Device-oriented Composite Endpoint (DoCE)12 months

Device-oriented Composite Endpoint (DoCE) defined as the composite of: Cardiovascular death, target vessel myocardial infarction, clinically indicated repeat revascularization of the target lesion at 12 months

Secondary Outcome Measures
NameTimeMethod
Major Adverse Cardiovascular Event (MACE)12 months

Composite event of cardiovascular (CV) death, non-fatal myocardial infarction (MI) and non-fatal stroke

Change from baseline in Global Longitudinal Strain measured by strain-rate echocardiography1 month

In the subgroup of patients with reduced Ejection Fraction, Change from baseline in Global Longitudinal Strain measured by strain-rate echocardiography

Change from baseline in left ventricular ejection fraction (LVEF) measured by echocardiography1 month

In the subgroup of patients with reduced Ejection Fraction, Change from baseline in left ventricular ejection fraction (LVEF) measured by echocardiography

Change of segmental movement of the territory revascularized measured by echocardiography1 month

In the subgroup of patients with reduced Ejection Fraction, Change from baseline segmental movement of the territory revascularized measured by echocardiography

Changes in left ventricular ejection fraction (LVEF)1 month

Changes in left ventricular ejection fraction (LVEF) from baseline and from 1 month post-procedure/pre-hospital discharge as assessed by echo in the subgroup of ventricular dysfunction

Trial Locations

Locations (21)

Hospital General Universitario de Elche

🇪🇸

Elche, Alicante, Spain

Hospital Universitario de Cruces

🇪🇸

Barakaldo, Spain

Hospital de La Santa Creu I Sant Pau

🇪🇸

Barcelona, Spain

Hospital General Universitario de Castellón

🇪🇸

Castelló, Spain

Hospital General Universitario de Ciudad Real

🇪🇸

Ciudad Real, Spain

Hospital Universitario San Pedro de Alcántara

🇪🇸

Cáceres, Spain

Hospital Universitari Dr. Josep Trueta

🇪🇸

Girona, Spain

Hospital Universitario Clínico San Cecilio

🇪🇸

Granada, Spain

Hospital Universitari Arnau de Vilanova

🇪🇸

Lleida, Spain

Hospital Universitario de Leon

🇪🇸

León, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Hospital Clínico Universitario Virgen de la Arrixaca

🇪🇸

Murcia, Spain

Hospital Parc Tauli

🇪🇸

Sabadell, Spain

Hospital Clinico Universitario de Salamanca

🇪🇸

Salamanca, Spain

Hospital Clínico Universitario de Santiago de Compostela

🇪🇸

Santiago de Compostela, Spain

Hospital Universitario de Toledo

🇪🇸

Toledo, Spain

Hospital Universitario Y Politécnico La Fé

🇪🇸

Valencia, Spain

Hospital Universitario Lozano Blesa

🇪🇸

Zaragoza, Spain

Hospital Universitari Vall D'Hebron

🇪🇸

Barcelona, Spain

Hospital Universitario A Coruña

🇪🇸

Coruña, Spain

Hospital Universitario Virgen Del Rocio

🇪🇸

Sevilla, Spain

© Copyright 2025. All Rights Reserved by MedPath